Home › All Companies › BLFS › Current Report

BIOLIFE SOLUTIONS INC (BLFS) — Current Report

AI-Powered SEC Filing Analysis

← All BLFS filings
Latest Current Report Filed: 2026-05-07

Key Insights

  • BioLife Solutions announced Q1 2026 financial results on May 7, 2026, indicating the company is actively reporting operational performance to shareholders and the market.
  • The 8-K filing references a press release (Exhibit 99.1) containing unaudited Q1 2026 results and operational highlights, but the actual financial figures and performance metrics are not detailed in this SEC document itself.
  • The filing was signed by Troy Wichterman, Chief Financial Officer, suggesting stable leadership continuity at the company during this reporting period.
  • As a Nasdaq-listed company with a standard form 8-K filing for earnings disclosure, BioLife Solutions is maintaining compliance with SEC reporting requirements and market transparency standards.
Sentiment: Neutral Significance: 3/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-05-07. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-03-02
  • BioLife Solutions, Inc. issued an investor presentation on March 2, 2026, which provides an update on the company's business and financial performance.
  • The presentation is available on the company's website, allowing investors to access the latest information about BioLife Solutions.
  • Investors should review the presentation to understand the company's current developments and future plans.
Sentiment: Positive Significance: 5/10
View Original Filing →

Other reports for BIOLIFE SOLUTIONS INC

Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.